home / stock / bhc / bhc news


BHC News and Press, Bausch Health Companies Inc. From 09/21/23

Stock Information

Company Name: Bausch Health Companies Inc.
Stock Symbol: BHC
Market: NYSE
Website: bauschhealth.com

Menu

BHC BHC Quote BHC Short BHC News BHC Articles BHC Message Board
Get BHC Alerts

News, Short Squeeze, Breakout and More Instantly...

BHC - League of United Latin American Citizens (LULAC) Joins OraPharma in the Fight Against Gum Disease

Partnership Aims to Educate Hispanic Communities About the Signs, Symptoms, and Prevalence of Gum Disease Collaboration Launches During Hispanic Heritage Month With Activations Featuring Patient Ambassador Alex Rodriguez LAVAL, QC / ACCESSWIRE / September 21, 2023 / In honor of Hispanic...

BHC - Bausch Health stock rebounds from Tuesday sell-off, helped by Jefferies upgrade

2023-09-20 11:29:47 ET More on Bausch Health Companies Seeking Alpha’s Quant Rating on Bausch Health Companies Bausch Health Companies Inc. 2023 Q2 - Results - Earnings Call Presentation Bausch + Lomb: $2.5bn M&A Deal Shows It Hasn't Learned From Pare...

BHC - BHC, PL and ATRA are among pre market gainers

2023-09-20 08:29:58 ET Exscientia ( EXAI ) +30% climbs as Merck KGaA joins AI drug discovery. Regulus Therapeutics  ( RGLS ) +16% Announces Positive Topline Data from the First Cohort of Patients in its Phase 1b Multiple-Ascending Dose  Clinical Trial o...

BHC - Why Shares of Bausch Health Companies Fell Tuesday

2023-09-19 13:46:35 ET Shares of Bausch Health Companies (NYSE: BHC) were down more than 9.5% as of 12:30 p.m. ET on Tuesday after the company announced that Chief Financial Officer Tom Vadaketh was departing and the company had a CFO transition plan. The healthcare company's st...

BHC - Bausch Health stock falls 9% amid news CFO is leaving company

2023-09-19 13:07:17 ET More on Bausch Health Companies Bausch + Lomb: $2.5bn M&A Deal Shows It Hasn't Learned From Parent's Mistakes Bausch Health CFO Vadaketh to step down Elliott Management opens new stakes in Seadrill, exits PayPal, Clarivate Baus...

BHC - Tracking John Paulson's Paulson & Company Portfolio - Q2 2023 Update

2023-09-19 04:37:07 ET Summary John Paulson's 13F portfolio value decreased by 15% to $1.02B this quarter. The top five positions in Paulson's portfolio are Bausch Health, BrightSphere Investment Group, Perpetua Resources, NovaGold, and Madrigal Pharma. Paulson made new stakes...

BHC - Bausch Health CFO Vadaketh to step down

2023-09-18 18:01:33 ET More on Bausch Health Companies Bausch Health Companies Q2 2023 Earnings Call Transcript Bausch Health Companies 2023 Q2 - Results - Earnings Call Presentation Bausch + Lomb: $2.5bn M&A Deal Shows It Hasn't Learned From Parent's Mistak...

BHC - Bausch Health Announces CFO Transition Plan

LAVAL, QC / ACCESSWIRE / September 18, 2023 / Bausch Health Companies Inc. (NYSE/TSX:BHC) ("BHC" or the "Company") today announced that Tom Vadaketh, Executive Vice President, Chief Financial Officer, has resigned from his role to pursue another opportunity, and will be leaving the Company effec...

BHC - Final Deadline Approaching for Bausch Health Companies Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Bausch Health Companies Inc. (BHC) Investors of September 25, 2023 Lead Plaintiff Deadline

The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Bausch Health Companies Inc. (“Bausch”) ( NYSE: BHC ). The action charges Bausch with violations of the federal securit...

BHC - New Bausch Health Treatment PrUCERIS(R) (budesonide) Aerosol Foam Now Available Across Canada to Treat Mild to Moderate Distal Ulcerative Colitis in Adults

LAVAL, QE / ACCESSWIRE / September 12, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is pleased to announce that following its approval by Health Canada the new treatment Pr UCERIS ® (budesonide) aerosol foam is now available across Canada to treat mild to moderate distal ulcera...

Previous 10 Next 10